Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Effects of dulaglutide on endothelial progenitor cells and arterial elasticity in patients with type 2 diabetes mellitus

Fig. 3

Changes in the values of EPA, EAA, EMA, ETF before and after treatment in MET group and MET-DUL group. MET metformin monotherapy group; MET-DUL metformin combined with dulaglutide treatment group; EPA proliferative ability of endothelial progenitor cells; EAA adhesion ability of endothelial progenitor cells; EMA migration ability of endothelial progenitor cells; ETF tubule forming ability of endothelial progenitor cells

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840